Apyx Medical Corp Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Apyx Medical Corp (APYX) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $27.62 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $27.62M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $31.14M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $31.74M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $25.14M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2026-06-30 | $27.62M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $31.14M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $31.74M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $25.14M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $29.30M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $31.01M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $31.74M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $28.01M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $32.68M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $37.28M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $43.65M 10-K · filed 2026-03-10 |
| 2023-09-30 | $22.13M 10-Q · filed 2024-11-08 |
| 2022-12-31 | $10.19M 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |